Coya Therapeutics (COYA) EBT Growth (1y) (2023 - 2026)
Coya Therapeutics (COYA) EBT Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | 1,140.26% |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | 88.57% |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | 9,460.35% |
| 10 | Coya Therapeutics | 97.60 Mn | 46.87 Mn | - | 1.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.37% |
| Dec 31, 2025 | 29.82% |
| Sep 30, 2025 | 41.88% |
| Jun 30, 2025 | -110.78% |
| Mar 31, 2025 | -44.63% |
| Dec 31, 2024 | -220.46% |
| Sep 30, 2024 | -84.62% |
| Jun 30, 2024 | 34.85% |
| Mar 31, 2024 | -26.91% |
| Dec 31, 2023 | -26.85% |
| Sep 30, 2023 | -70.20% |
| Jun 30, 2023 | -28.80% |
| Mar 31, 2023 | -134.11% |